KWKatherine A. Weissler

Katherine A. Weissler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katherine A. Weissler has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Chen Yao

    Department of Immunology, University of Texas Southwestern Medical Center, Dallas, USA

    1 shared publication
  • Daniella M. Schwartz

    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

    1 shared publication
  • Jenny Li

    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

    1 shared publication
  • John O’sHea

    Laboratory of Lymphocyte Nuclear Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA

    1 shared publication
  • Justin Lack

    Collaborative Bioinformatics Resource, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

    1 shared publication
  • Karen Laky

    Laboratory of Allergic Diseases National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Bethesda Maryland USA

    1 shared publication

Latest Publications

  • TGFβ prevents IgE-mediated allergic disease by restraining T follicular helper 2 differentiation

    by Tamara T. Haque, Katherine A. Weissler, Zoe Schmiechen, Karen Laky, Daniella M. Schwartz, Jenny Li, Michela Locci, Mathilde Turfkruyer, Chen Yao, Paul Schaughency, et al.

    Allergic diseases are common, affecting more than 20% of the population. Genetic variants in the TGFβ pathway are strongly associated with atopy. To interrogate the mechanisms underlying this association, we examined patients and mice with Loeys-Dietz syndrome (LDS) who harbor missense mutations in the kinase domain of TGFΒR1/2 . We demonstrate that LDS mutations lead to reduced TGFβ signaling and elevated total and allergen-specific IgE, despite the presence of wild-type T regulatory cells in a chimera model. Germinal center activity was enhanced in LDS and characterized by a selective increase in type 2 follicular helper T cells (T FH 2). Expression of Pik3cg was increased in LDS T FH cells and associated with reduced levels of the transcriptional repressor SnoN. PI3Kγ/mTOR signaling in LDS naïve CD4 + T cells was elevated after T cell receptor cross-linking, and pharmacologic inhibition of PI3Kγ or mTOR prevented exaggerated T FH 2 and antigen-specific IgE responses after oral antigen exposure in an adoptive transfer model. Naïve CD4 + T cells from nonsyndromic allergic individuals also displayed decreased TGFβ signaling, suggesting that our mechanistic discoveries may be broadly relevant to allergic patients in general. Thus, TGFβ plays a conserved, T cell–intrinsic, and nonredundant role in restraining T FH 2 development via the PI3Kγ/mTOR pathway and thereby protects against allergic disease.